not long now :) , page-12

Hi MarkRed,

Met a group of oncology specialists at a biotech summit (Australasian Biotech Summit).
Prima weren't even presenting but they brought them up.
They run a few venture capital companies that specialise in investing in cancer biotechs. Mostly invest in private companies but they rate Prima highly.

Said they were invested in Prima and were about to buy up some more. This was about 2 months ago.

At the end of the day they may have been pulling my leg, but I doubt it and as others have pointed out the info that is freely available shows the stock is well undervalued (compare to DNDN if you will).

Once again, do your own research.

If CVac fails then nothing else will matter...the share price will collapse. But if it works or even the build up to the final date will see the stock rise enormously in my opinion to a massive figure compared to now.

As good as the upside is $$$ wise, the cure is the main thing. It will change the way numerous cancers are treated. Hope CVac works!!
___________________________________________________
Stock held: PRR, MSB, PAB, CDY, APH, MYX, ACTC